Yu Bin Seo
Overview
Explore the profile of Yu Bin Seo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
842
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choi Y, Jung J, Kang M, Choi M, Choi W, Seo Y, et al.
Vaccine
. 2024 Dec;
46():126676.
PMID: 39733480
No abstract available.
2.
Choi Y, Jung J, Kang M, Choi M, Choi W, Seo Y, et al.
Vaccine
. 2024 Nov;
44:126506.
PMID: 39591703
Introduction: Coronavirus 2019 (COVID-19) vaccination rates in pregnant women remain low owing to safety concerns. When evaluating vaccine safety, comparisons with unvaccinated individuals may lead to healthy vaccinee bias. This...
3.
Na S, Eom J, Seo Y, Park S, Kim Y, Song W, et al.
J Korean Med Sci
. 2024 May;
39(18):e151.
PMID: 38742291
Background: Catheter-associated urinary tract infections (CAUTIs) account for a large proportion of healthcare-associated infections and have a significant impact on morbidity, length of hospital stay, and mortality. Adherence to the...
4.
Seo J, Kim S, Kim Y, Kim E, Kim T, Kim T, et al.
Infect Chemother
. 2024 Mar;
56(1):122-157.
PMID: 38527781
"Long COVID" is a term used to describe a condition when the symptoms and signs associated with coronavirus disease 2019 (COVID-19) persist for more than three months among patients infected...
5.
Choi M, Hyun H, Heo J, Seo Y, Noh J, Cheong H, et al.
Heliyon
. 2024 Mar;
10(5):e27211.
PMID: 38468934
Background: Data on the durability of booster dose immunity of COVID-19 vaccines are relatively limited. Methods: Immunogenicity was evaluated for up to 9-12 months after the third dose of vaccination...
6.
Park J, Park H, Na S, Seo Y, Lee J
BMC Infect Dis
. 2024 Feb;
24(1):235.
PMID: 38383425
Background: With the global increase in the older population, the proportion of those receiving care in long-term care facilities (LTCFs) has also been increasing. We assessed the epidemiology, antibiotic susceptibility,...
7.
Nham E, Yoon J, Choi M, Seo Y, Lee J, Choi W, et al.
J Korean Med Sci
. 2024 Feb;
39(5):e45.
PMID: 38317446
Background: In Korea, there are no surveillance programs for vaccines that are not included in the national immunization program (NIP), and vaccine safety monitoring in the adult population is inadequate....
8.
Choi M, Na Y, Hyun H, Nham E, Yoon J, Seong H, et al.
Clin Microbiol Infect
. 2023 Dec;
30(5):646-652.
PMID: 38101473
Objective: This nationwide cohort study compared the incidence of adverse events of special interest (AESIs) between adenoviral vector-based (ChAdOx1) and mRNA-based (BNT162b2 or mRNA-1273) coronavirus disease 2019 (COVID-19) vaccines. Methods:...
9.
Choi Y, Seo Y, Seo J, Lee J, Nham E, Seong H, et al.
J Clin Med
. 2023 Dec;
12(23).
PMID: 38068427
Antiviral treatment reduces the severity and mortality of SARS-CoV-2 infection; however, its effectiveness against long COVID-19 is unclear. This study aimed to evaluate the effectiveness of antiviral drugs in preventing...
10.
Hyun H, Jang A, Suh J, Bae I, Choi W, Seo Y, et al.
J Korean Med Sci
. 2023 Oct;
38(42):e330.
PMID: 37904655
Background: Targeted risk population has been highly vaccinated against pneumococcal diseases in South Korea. Despite this, the pneumococcal serotype distribution is evolving, which impedes efficient roll-out of vaccines. Methods: This...